CVE-2026-27970

Feb. 27, 2026, 5:11 p.m.

7.6
High

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Versions prior to 21.2.0, 21.1.16, 20.3.17, and 19.2.19 have a cross-Site scripting vulnerability in the Angular internationalization (i18n) pipeline. In ICU messages (International Components for Unicode), HTML from translated content was not properly sanitized and could execute arbitrary JavaScript. Angular i18n typically involves three steps, extracting all messages from an application in the source language, sending the messages to be translated, and then merging their translations back into the final source code. Translations are frequently handled by contracts with specific partner companies, and involve sending the source messages to a separate contractor before receiving final translations for display to the end user. If the returned translations have malicious content, it could be rendered into the application and execute arbitrary JavaScript. When successfully exploited, this vulnerability allows for execution of attacker controlled JavaScript in the application origin. Depending on the nature of the application being exploited this could lead to credential exfiltration and/or page vandalism. Several preconditions apply to the attack. The attacker must compromise the translation file (xliff, xtb, etc.). Unlike most XSS vulnerabilities, this issue is not exploitable by arbitrary users. An attacker must first compromise an application's translation file before they can escalate privileges into the Angular application client. The victim application must use Angular i18n, use one or more ICU messages, render an ICU message, and not defend against XSS via a safe content security policy. Versions 21.2.0, 21.1.6, 20.3.17, and 19.2.19 patch the issue. Until the patch is applied, developers should consider reviewing and verifying translated content received from untrusted third parties before incorporating it in an Angular application, enabling strict CSP controls to block unauthorized JavaScript from executing on the page, and enabling Trusted Types to enforce proper HTML sanitization.

Product(s) Impacted

Vendor Product Versions
Angular
  • Angular
  • *, 21.2.0

Weaknesses

Common security weaknesses mapped to this vulnerability.

CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

*CPE(s)

Affected systems and software identified for this CVE.

Type Vendor Product Version Update Edition Language Software Edition Target Software Target Hardware Other Information
a angular angular / / / / / node.js / /
a angular angular / / / / / node.js / /
a angular angular / / / / / node.js / /
a angular angular 21.2.0 next0 / / / node.js / /
a angular angular 21.2.0 next1 / / / node.js / /
a angular angular 21.2.0 next2 / / / node.js / /
a angular angular 21.2.0 next3 / / / node.js / /
a angular angular 21.2.0 rc0 / / / node.js / /

CVSS Score

7.6 / 10

CVSS Data - 4.0

  • Attack Vector: NETWORK
  • Attack Complexity: LOW
  • Attack Requirements: PRESENT
  • Privileges Required: NONE
  • User Interaction: PASSIVE
  • Scope:
  • Confidentiality Impact: HIGH
  • Integrity Impact: HIGH
  • Availability Impact: NONE
  • Exploit Maturity: NOT_DEFINED
  • CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

    View Vector String

Timeline

Published: Feb. 26, 2026, 2:16 a.m.
Last Modified: Feb. 27, 2026, 5:11 p.m.

Status : Analyzed

CVE has been recently published to the CVE List and has been received by the NVD.

More info

*Disclaimer: Some vulnerabilities do not have an associated CPE. To enhance the data, we use AI to infer CPEs based on CVE details. This is an automated process and might not always be accurate.